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Resumen
Objetivo. Analizar los costos y la efectividad de una inter-
vención basada en visitas de enfermería en casa a ancianos
hipertensos comparada con el tratamiento usual otorgado
por el médico familiar. Material y métodos. Una muestra
de 4 777 sujetos de 60 años y más derechohabientes del
Instituto Mexicano del Seguro Social (IMSS) fueron someti-
dos a escrutinio. Aquellos con cifras sistólica o diastólica
iguales o superiores a 160/90 mm Hg fueron asignados alea-
toriamente al grupo de intervención o al control. La inter-
vención consistió en visitas de enfermera en casa que daban
promoción de la salud. La evaluación económica fue conside-
rada desde una perspectiva del paciente y de los servicios de
salud. Costos directos e indirectos fueron considerados como
incrementales. La efectividad fue medida en términos de cos-
to por mmHg reducido. Resultados. Trescientos cuarenta y
cinco participantes fueron aleatorizados al grupo de inter-
vención y comparados con 338 controles. Al final del perio-
do de intervención la diferencia en el cambio promedio en
presión arterial sistólica fue de 3.31 mm Hg (IC 95% 6.32,
0.29; p=0.03) comparado con el grupo control. La diferencia
en presión arterial diastólica fue de 3.67 mm Hg (IC 95%
5.22, 2.12; p<0.001). El costo total de la intervención fue de
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Abstract
Objective. To analyse the costs and the effectiveness of an
intervention of  home visits made by nurses to elderly peo-
ple versus usual care given by the family medicine units. Ma-
terial and Methods. A sample of 4 777 subjects aged 60
years and over covered by the Mexican Institute of Social
Security (Instituto Mexicano del Seguro Social, IMSS) were
screened.  Those with a systolic and/or diastolic blood pres-
sure level higher or equal than 160/90 mm Hg were random-
ly allocated to the intervention or control groups. The
intervention consisted of visits at home by nurses who gave
health and lifestyle advice to the participants. The economic
evaluation was considered from a health services and patient
perspective. Direct and indirect costs were calculated as in-
cremental. Effectiveness was measured in terms of cost per
millimetre of mercury reduced. Results.  Three hundred and
forty five participants were allocated to the intervention group
and compared with 338 controls.  At the end of the interven-
tion period the difference in the mean change in systolic blood
pressure was 3.31 mm Hg (95% CI 6.32, 0.29; p=0.03) compa-
ring with the control group. In diastolic blood pressure
the difference was 3.67 (95% CI 5.22, 2.12; p<0.001). The
total cost of the intervention was 101 901.66 pesos. The in-
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The ageing population  and the concomitantincreasing prevalence of non-communicable
diseases is an important issue in the health agenda of
Mexico.1,2  Different ways of providing health care for
the elderly are being studied to identify the most
effective policies. A pragmatic randomised  trial of
home visits made by nurses to elderly people with
hypertension in Mexico has reported the effectiveness
of this intervention in reducing blood pressure levels
at six months.3,4 There was a significant reduction in
blood pressure, as well as an increased proportion of
participants undertaking regular  brisk walking. There
was also a significant increase in the proportion of
participants on hypotensive medication.  However,
there was no difference in weight reduction or  salt
excretion between the intervention and control group.
Financial resources for health are inevitably limited and
there are many competing demands. It is therefore
important to determine the cost-effectivenss of a policy
before recommending that it be  incorporated in  health
care provided by  the Mexican Institute of Social Secu-
rity (Instituto Mexicano del Seguro Social (IMSS). A
number of studies have evaluated the cost and effects
of antihypertensive drugs,5-8 but far fewer have eva-
luated health promotion strategies for reducing hy-
pertension, and even fewer have considered the effect
in old people.  Health checks to reduce cardiovascu-
lar risk factors in the general population9,10 have been
shown to be cost-effective although, this depends on
the duration of the effect.
This report estimates the incremental costs and
effects of home visits made by nurses to elderly people
in comparison with the usual care provided by the
family medicine units.
Material and Methods
The design of the trial, methods and main findings have
been reported previously.3,4 Briefly, 4 777 participants
aged 60 years and over were screened. Those pre-
viously known as hypertensives or those with new
diagnosis who had a systolic and/or diastolic blood
pressure level higher or equal to 160/90 mm Hg re-
spectively, were randomly allocated to the interven-
tion or control arm. The intervention consisted of visits
at home at least fortnightly by nurses during a six
month period. The nurses were first given training
about ageing, clinical aspects of hypertension, personal
interviews, health behaviour change models, process
of negotiation and ethical aspects of home visits.
During visits, the nurse measured blood pressure and
the nurse and patient reviewed information from the
baseline health check, and discussed possible lifestyle
changes.  The nurse tried to guide their patients to a
healthier lifestyle and suggested different alternative
ways to achieve the changes and negotiated specific
targets. The nurse also reviewed the pharmacological
treatment and compliance was encouraged.  The
patient led the process of negotiation, while the nurse
provided information about risks and benefits from
lifestyle change. Both groups continued to receive the
usual care provided by the family physicians. The trial
did not interfere with the care given by the doctors at
the family medicine units. A different team of nurses
measured blood pressure and weighed the participants
at  baseline and at final follow-up. They also collected
a sample of urine for calculating sodium excretion and
administered a questionnaire to ascertain the presence
of  risk factors, use of medication and self-reported level
of physical activity. There were 364  participants
randomised to the intervention group and 354 to the
control group. The 19 participants in the intervention
group and 16 in the control group dropped out before
the final evaluation. The flow of the subjects through the
study is presented in Figure 1. Baseline characteristics of
the participants are included in Table I.
Costs
The evaluation was considered from a health services
and patient perspective. All costs are reported in 1998
Mexican pesos and US dollars. Costs were not discount-
tervention cost per patient was 34.61 pesos (US$3.78), (CI
95% 34.44, 35.46).  The cost-effectiveness ratios was 10.46
pesos  (US$1.14) for systolic (CI 95% 129.31, 5.51) and 9.43
(US$1.03) for diastolic (CI 95% 19.90, 2.49). Conclusions.
The reduction in blood pressure obtained may well justify
the small incremental cost of the intervention. The English
version of this paper is available too at: http://www.insp.mx/
salud/index.htm
Key words: hypertension; elderly population; cost effective-
ness; Mexico
101,901.66 pesos. El costo por paciente fue de 34.61 pesos
(US$3.78), (IC 95% 34.44, 35.46). La razón de costo efectivi-
dad fue de 10.46 pesos (US$1.14) para presión sistólica (IC
95% 129.31, 5.51) y 9.43 (US$1.03) para presión diastólica
(IC 95% 19.90, 2.49). Conclusiones. La reducción de la
presión arterial parece valer el costo incremental de la inter-
vención. El texto completo en inglés de este artículo tam-
bién está disponible en: http://www.insp.mx/salud/index.html
Palabras clave: hipertensión; población anciana; costo-
efectividad; México
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ed since the time period of the intervention was six
months, apart from the cost of the sphygmomanome-
ters, which was discounted assuming a  capital life
expectancy of five years and a discount rate of 6%.
Costs which related to the process of research rather
than the provision of the intervention were excluded.
All the costs of the intervention were considered to be
incremental to the cost of existing care since the family
medicine units do not have an existing programme.
Nurse time was recorded during the trial, including
the duration of each visit, the time spent travelling,
and time spent on general issues such as planning, co-
difying and reporting. The cost of transport was also
included.  Using this information, an average cost of a
visit was calculated, which is the cost of nurse time
during the consultation plus time spent travelling. The
unit costs of the time of the nurses and their instruc-
tors were calculated from their salaries (17.50 pesos per
hour for the nurses). Supplies and stationery costs were
collected from institutional records. Equipment costs
(sphygmomanometers and stethoscopes) were col-
lected from the institutional distributor. Clinic/office
space was costed using the daily accounting cost of a
room at IMSS. The impact of the intervention on the
number of family physicians consultations was mea-
sured. Patient costs were investigated.
A cost for each patient was calculated by multi-
plying the number of visits that individual had received
by the average cost of a visit plus the average of the
other costs (equipment, office space, training, supplies).
A confidence interval for mean cost, as well as mean
effect, was calculated using the t-distribution with the
variation in cost being attributable to the variation in
the number of visits received.  Similarly the difference
in costs, or difference in effects was also calculated.
Cost/effectiveness was measured in terms of cost
per millimetre of mercury reduced. Confidence inter-
vals for the cost-effectiveness ratios were estimated
using Fieller’s method, which takes account of the
skewness of the distribution of the ratio.11
FIGURE 1. FLOW OF SUBJECTS THROUGH THE STUDY. MEXICAN INSTITUTE OF SOCIAL SECURITY (INSTITUTO MEXICANO
DEL SEGURO SOCIAL), 1998
Subjects aged 60 +
Original sample
March 1997
N= 5 433
Deaths Refusals Not located
n= 216 n= 54 n= 386
Phase one screening
Feb-July 1998
N= 4 777
Baseline phase
Eligible for study
August-Sept 1998
N= 911
Randomisation
N= 718
Final phase
April 1999
N= 703
Deaths n= 8
Moved away n= 101
Approached for study n= 782
Refusals n= 64
Control group
n= 354
October 1998
Refusals n= 3
Deaths n= 10
Not located n= 3
Control group
n= 338
Intervention group
n= 364
October 1998
Deaths n= 9              Refusals n= 6
Refusals n= 1
Deaths n= 1
Not located n= 2
Intervention groups
n= 345
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Results
At the end of the intervention period the difference in
the mean change was a fall of 3.31 mm Hg (95% CI
6.32,  0.29, p=0.03) in systolic blood pressure and a fall
of 3.67 mm Hg  (95% CI 5.22, 2.12 p<0.001) in diastolic
blood pressure comparing the intervention group with
the control group. In the intervention group, 12.9% of
participants reported an increase in brisk walking,
compared with 5.2% in the control group (p=0.0004),
and the proportion of people not anti-hypertensive
medication  decreased from 28.4% to 15.9%, compared
to a decrease from 32.2% to 26.9% in the control group
(p=0.001).
Costs
Cost items related to the training course are described
in Table II. Table III presents the costs of equipment.
Indirect costs such as patient or family time were not
included because when the nurses asked, none of the
participants reported a cost value of the time spent
during the visits. The total cost of the transport was
$7 207.60 pesos (US$787.71), the average transport cost
per visit was $2.70 pesos (CI 95% 2.42, 2.95 pesos).
The average time per consultation was 43.58 minutes
(CI 95% 41.16, 45.89 min.).  The total number of visits
to the participants was 2 944 (mean for a participant
8.53, std. dev.=2.10). The total cost of the intervention
nurses was 59 096.82 pesos (US$6,180.99). The total
cost of the intervention was then calculated as follows:
Cost = [number of consultations per patient ave-
rage cost of a consultation (nurse time consultation+time
travelling)+cost travelling] + other costs (equipment,
office space, training, supplies) = 101 901.66 pesos
(US$11,136.79).
The average intervention cost per patient was 34.61
pesos (US$3.78),  (p=0.000, CI 95% 34.44, 35.46). This
cost was not significantly different (p=0.61) in men and
women (the  cost for one woman was 35.05 pesos
(US$3.83) and for one man  34.78 pesos (US$3.80).
The total number of clinic visits to the family phy-
sicians by the participants was also calculated. There
were 1 395 clinic visits in two hundred and sixty five
participants (mean=5.26, std. dev.=2.57) in the inter-
vention group and 1,392 visits in 259 participants
(mean=5.37, std. dev.=1.85) in the control group. The
difference between the groups was not significant
(p=0.22).
Effects and cost/effectiveness ratios
The differences in the mean change of systolic and di-
astolic blood pressure were used as the effectiveness
measurements. The cost-effectiveness of the interven-
tion  was  10.46 pesos (US$1.14) per millimetre reduc-
tion in  systolic blood pressure or 9.43 pesos (US$1.03)
per millimetre reduction in diastolic blood pressure.
Confidence intervals for the cost-effectiveness ratios
Table 1
BASELINE CHARACTERISTICS OF INTERVENTION
AND CONTROL GROUPS. MEXICAN INSTITUTE
OF SOCIAL SECURITY (INSTITUTO MEXICANO
DEL SEGURO SOCIAL), 1998
Control Intervention
n=354 n=364
Mean age  in years (SD) 70.34(6.92) 70.8(7.11)
Female, % 65.0 62.9
Education level, %
Primary 57.6 55.0
Secondary 13.6 12.1
High school and more 3.4 5.5
Single, widowed or divorced, % 36.1 40.6
Lives alone, % 15.5 8.2
Income/month*, %
$10-$109 55.6 56.6
$110-$209 21.5 26.1
$210 and more 4.0 3.8
No own income 18.9 13.5
Lifestyle risk factors, %
Current Smoking 14.2 12.5
Clinical risk factors, %
Diabetes mellitus 26.0 27.1
Angina pectoris 1.7 2.2
Acute myocardial infarction 4.2 5.8
Renal failure 2.0 0.6
Hypercholesterolaemia 16.1 12.2
Previously known hypertension 81.4 83.2
Mean weight in Kg (SD) 67.1 (11.96) 68.4 (13.4)
Body mass index Kg/m2 (SD) 28.6 (4.83) 28.7 (5.21)
Sodium excretion in mmol/lt (SD) 95.2 (47.1) 94.9 (48.81)
Not regular  walking,  % 39.0 39.8
Not brisk walking, % 78.3 72.9
Mean blood pressure in mmHg (SD)
Systolic 161.9(18.4) 162.1 (18.4)
Diastolic 90.8(9.4) 90.9 (10.4)
Blood pressure measurements, %
Diastolic  ≥ 90 mm Hg 39.0 39.3
Systolic  ≥ 160 mm Hg 31.9 31.6
Diastolic ≥90 and systolic ≥160mm Hg 29.1 29.1
  *American dollars
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are presented in Table IV. The cost of the control group
is zero because a) the intervention is considered to be
an incremental cost and b) the cost of family physician
visits was not included as there was no significant dif-
ference between the trial arms. Variances and stand-
ard deviations of the effects (S2ET, S
2
EC, and SET) assumed
the values of change in systolic and diastolic blood
pressure. The intervention cost per patient (CT) was
34.61 pesos (SCT=4.86, S
2
CT=23.68 pesos). Symbol rT re-
fers to the sample correlation coefficient of the cost an
effect in the intervention group (Systolic rT=0.028 and
diastolic rT=0.003). Table 4 includes values of the three
coefficients of variation (Cdd,  Cnn and Cnd) and the re-
sulting confidence intervals for systolic and diastolic
cost-effectiveness ratios.
Table II
COST OF TRAINING. MEXICAN INSTITUTE OF SOCIAL SECURITY
(INSTITUTO MEXICANO DEL SEGURO SOCIAL), 1998
Recruitment and training of nurses
Per month Per year Per hour Time Cost in pesos Cost in* dollars
Value time of trainer team:
Cardiologist 8 620.82 122 258.96 78.37 3 hrs 235.11 25.70
Geriatrician 8 620.82 122 258.96 78.37 4 hrs 313.48 34.26
Physical therapist 8 620.82 122 258.96 78.37 3 hrs 235.11 25.70
Psychiatrist 8 620.82 122 258.96 78.37 3 hrs 235.11 25.70
Supervisor 3 150.00 48 609.04 25.32 80 hrs 2 025.60 221.38
Researcher 8 620.82 122 258.96 78.37 80 hrs 6 269.60 685.20
Clinic space for course Two weeks 11 500.00 1 256.83
Value time of nine nurses during the course 2 800.00 Two weeks 12 600.00 1 377.05
Partial total: training and clinic space 33 414.01 3 651.82
*Exchange rate 1998=9.15 pesos/dollar
Table IV
COEFFICIENTS OF VARIATION AND CONFIDENCE
INTERVALS FOR COST EFFECTIVENESS RATIOS.
MEXICAN INSTITUTE OF SOCIAL SECURITY (INSTITUTO
MEXICANO DEL SEGURO SOCIAL), 1998
Systolic blood Diastolic blood
pressure pressure
Coefficient of variation of
numerator of R^ (Cnn) 0.0000573 0.0000573
Coefficient of variation of
denominator of R^ (Cdd) 0.22 0.0410
Coefficient of variation of
denominator/numerator of R^ (Cnd) 0.0000688 0.00000315
Cost effectiveness ratio (R^)
Pesos 10.46 9.43
US$ 1.14 1.03
95% Confidence Interval
Pesos 129.31   5.51 19.90   2.49
US$ 14.13   0.60 2.17    0.27
Table III
COST OF EQUIPMENT. MEXICAN INSTITUTE
OF SOCIAL SECURITY (INSTITUTO MEXICANO
DEL SEGURO SOCIAL), 1998
Cost per Total costs
Equipment unit pesos Pesos Dollars+
Sphygmomanometers (nine)* 255.96 2 303.64 251.76
Stethoscope (nine) 55.00 495.00 54.10
Uniforms for nine nurses 150.00 1 350.00 147.54
Total cost of supplies and stationery
(sheets, photocopies, pencils, erasers)  5 242.19 5 242.19 572.92
Partial total: equipment 9 390.83 1 032.32
*Annualised +exchange rate 1998=9.15 pesos/dollar
Discussion
Much research has been published in the area of effec-
tive antihypertensive therapy, patient management
guidelines and life-style management, but optimal meth-
ods for the delivery of care have not been fully explored.
With this perspective, the aim of this study  was to mea-
sure the incremental costs and effects of home visits by
a nurse to elderly people with hypertension in Mexico.
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The cost effectiveness of the intervention was 10.5
pesos (US$1.1)  per mm Hg reduction of systolic blood
pressure and 9.4 pesos (US$1.0) per mm Hg reduc-
tion of diastolic blood pressure. This seems on face
value to be a cost-effective intervention.  However,  it
is not possible to draw a firm conclusion because it is
not possible to make comparisons with alternative
health care interventions based in Mexico which used
other measures of effectiveness. The tool of economic
analysis has emerged only recently in Mexico and lit-
tle information exists. We cannot determine, therefore,
if nurse visits to the elderly  is the most cost-effective
alternative. However, the estimated cost per millime-
tre of mercury reduction in blood pressure suggests
that this intervention will prove to be highly cost ef-
fective.
This study is based on an outcome of  reduction
in blood pressure, which  is an immediate outcome.
We do not have any information on the sustainability
of the intervention, and the future benefits of the
intervention in terms of mortality, morbidity or quality
of life are unknown. Because the target group is elderly,
it is not possible to model the effects of blood pressure
reduction on mortality. Models for estimating life years
gained after blood pressure reduction  have been
criticised for discriminating against older people, due
to a shorter life expectancy of older people.12 Unfortu-
nately, models have not been  developed for people
over 70 years old. As a consequence the utilization of
modelling would underestimate the cost-effective-
ness ratio.
The number of clinic consultations with the fami-
ly physician was not statistically different between the
groups. If future benefits are achieved in the
intervention group, it is possible that there will be a
decrease in utilisation rates for second and third levels
of care and a decrease in the disability rates. On the
other hand the intervention lead to increased prescrib-
ing of antihypertensive drugs and this has not been
considered in our estimate of cost. Indirect costs were
not included in the analysis because none of the par-
ticipants reported any.  One of the reasons for this was
that the nurse always arranged the appointment with
the participant and he/she could choose a time that
was convenient. By arranging home visits at times that
are convenient to the participant, indirect costs can be
greatly reduced. Many health policy makers argue that
health promotion practices and preventive care are a
way of reducing health care costs. However, the idea
that health promotion and preventive strategies are
cheap and will save money, is too simplistic.  Indeed,
in the case of the elderly population, health promotion
activities could add to the costs of the medical expend-
iture but they will also represent future benefits in
terms of a better quality of life, a decrease in disability
and the possibility of a successful ageing.13
Recognition  that health can be promoted for the
elderly to improve the quality of life  has increased in
the last few years14 but the process by which research
data are incorporated into a clinical setting is
complicated. Economic features, organisational
aspects, uncertainty about the usefulness of the results,
technical barriers are some of the obstacles in the
process of linking research into policy.15 Ensuring that
the health promotion strategy that we tested is effec-
tive is an important step, but not enough. As is true
everywhere in the world, institutional resources in
Mexico will remain limited and interventions for the
elderly must be shown to be cost-effective if they are
to compete against the resource demands of other
worthwhile interventions.  The intervention evaluated
in this study has been shown to be effective at very
small cost, but whether this represents good value
compared with other health interventions remains to
be determined.  Moreover, there is, as yet, no relevant
data on the effectiveness or cost of other possible
interventions aimed at blood pressure reduction in an
elderly Mexican population, such as self help groups
and future research has to be done in this area.
This study is important because introduces the tool
of the economic analysis  in the arena of health
promotion for elderly people. In México, health system
has to be reorganized in order to response to the
growing needs of this group of age and research is a
key element in this process. Hypertension and their
consequences  (stroke and coronary heart disease) is
the most important cause of mortality and disability
among the elderly.  Cost-effective strategies that
improves health and promotes healthy aging  are
crucial if we want to diminish an increasing utiliza-
tion of third level hospitals and the subsequent costs.
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